The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway
2022 · Clinical Immunology · 21 citations
https://doi.org/10.1016/j.clim.2022.109217